Senior Chief Petty Officer Ed Stift, U.S. Navy (retired), was the first patient to receive tumor-infiltrating lymphocyte (TIL) therapy at Vanderbilt-Ingram Cancer Center. Watch Ed, his wife, Nora, and his care team talk about his treatment, the Department of Veterans Affairs partnership that made it possible, and the time he’s grateful to spend with his family.
Types of Cellular Therapies
